- Home
- INTA vs ALKS Comparison
INTA vs ALKS Comparison
Compare INTA & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INTA
- ALKS
- Stock Information
- Founded
- INTA 2000
- ALKS 1987
- Country
- INTA United States
- ALKS Ireland
- Employees
- INTA N/A
- ALKS N/A
- Industry
- INTA Computer Software: Prepackaged Software
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- INTA Technology
- ALKS Health Care
- Exchange
- INTA Nasdaq
- ALKS Nasdaq
- Market Cap
- INTA 4.6B
- ALKS 4.8B
- IPO Year
- INTA 2021
- ALKS 1991
- Fundamental
- Price
- INTA $54.53
- ALKS $30.56
- Analyst Decision
- INTA Buy
- ALKS Buy
- Analyst Count
- INTA 10
- ALKS 13
- Target Price
- INTA $68.38
- ALKS $38.85
- AVG Volume (30 Days)
- INTA 685.6K
- ALKS 1.6M
- Earning Date
- INTA 05-06-2025
- ALKS 07-23-2025
- Dividend Yield
- INTA N/A
- ALKS N/A
- EPS Growth
- INTA N/A
- ALKS N/A
- EPS
- INTA N/A
- ALKS 2.09
- Revenue
- INTA $483,457,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- INTA $18.75
- ALKS N/A
- Revenue Next Year
- INTA $14.48
- ALKS $4.11
- P/E Ratio
- INTA N/A
- ALKS $14.52
- Revenue Growth
- INTA 17.70
- ALKS N/A
- 52 Week Low
- INTA $31.08
- ALKS $22.90
- 52 Week High
- INTA $77.74
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- INTA 45.50
- ALKS 54.70
- Support Level
- INTA $53.88
- ALKS $29.70
- Resistance Level
- INTA $57.64
- ALKS $31.76
- Average True Range (ATR)
- INTA 1.52
- ALKS 0.73
- MACD
- INTA -0.19
- ALKS -0.01
- Stochastic Oscillator
- INTA 13.00
- ALKS 66.02
About INTA Intapp Inc.
Intapp Inc is a provider of industry-specific, cloud-based software solutions for the professional and financial services industry. It empowers private capital, investment banking, legal, accounting, and consulting firms with the technology needed to meet rapidly changing client, investor, and regulatory requirements. Geographically, it derives a majority of its revenue from the United States and also has a presence in the United Kingdom and the Rest of the world.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.